← Browse by Condition
Medical Condition
melanoma
Total Trials
28
Recruiting Now
28
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2
NCT05867004
Recruiting
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Enrollment
100 pts
Location
France
Sponsor
Institut Claudius Regaud
NCT06418204
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Enrollment
2,000 pts
Location
United States, Puert...
Sponsor
Wake Forest University Health ...
NCT06272864
Recruiting
BostonGene and Exigent Genomic INsight Study
Enrollment
400 pts
Location
United States
Sponsor
BostonGene
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT07092670
Recruiting
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
Enrollment
270 pts
Location
Italy
Sponsor
Intergruppo Melanoma Italiano
NCT07260591 Phase 1
Recruiting
VSV-02 Compassionate Use in Advanced Solid Tumors
Enrollment
6 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06229340 Phase 2
Recruiting
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Enrollment
20 pts
Location
Russia
Sponsor
N.N. Petrov National Medical R...
NCT05334069
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i...
NCT04386967 Phase 1, Phase 2
Recruiting
OH2 Injection in Solid Tumors
Enrollment
30 pts
Location
China
Sponsor
Binhui Biopharmaceutical Co., ...
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT05076760 Phase 1
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Memgen, Inc.
NCT04572451 Phase 1
Recruiting
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Enrollment
50 pts
Location
United States
Sponsor
Yana Najjar
NCT04729543 Phase 1, Phase 2
Recruiting
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
Enrollment
20 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
NCT02870244 Phase 1
Recruiting
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Enrollment
18 pts
Location
United States
Sponsor
Loyola University
NCT01772771
Recruiting
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Enrollment
12,000 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05522660 Phase 3
Recruiting
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Enrollment
180 pts
Location
Italy, Netherlands, ...
Sponsor
ETOP IBCSG Partners Foundation
NCT06887348
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Enrollment
50 pts
Location
United States, Austr...
Sponsor
Replimune Inc.
NCT07161310
Recruiting
Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
Enrollment
45 pts
Location
Germany
Sponsor
Goethe University
NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06666634
Recruiting
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
Enrollment
29 pts
Location
Netherlands
Sponsor
The Netherlands Cancer Institu...
NCT05899465 Phase 3
Recruiting
Perioperative Treatment With Tranexamic Acid in Melanoma
Enrollment
1,204 pts
Location
Denmark
Sponsor
University of Aarhus
NCT04193956
Recruiting
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
Enrollment
3,500 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
NCT05483400 Phase 2
Recruiting
Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors
Enrollment
97 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
NCT04616443 Phase 1, Phase 2
Recruiting
OH2 Injection in Combination With HX008 for Melanoma.
Enrollment
60 pts
Location
China
Sponsor
Binhui Biopharmaceutical Co., ...
NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT06281678 Phase 2
Recruiting
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Enrollment
178 pts
Location
United States
Sponsor
Innovent Biologics (Suzhou) Co...
NCT05264974 Phase 1
Recruiting
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Enrollment
18 pts
Location
United States
Sponsor
University of Florida
NCT07042243
Recruiting
The Florida ASCENT Study
Enrollment
100 pts
Location
United States
Sponsor
University of Florida